• Arrowhead Pharmaceuticals, Inc.: Baptista Research downgrades to buy from hold with a price target reduced from USD 30 to USD 28.90.
  • Assurant, Inc.: Piper Sandler & Co downgrades to neutral from overweight with a target price of USD 200.
  • Capri Holdings Limited: Baptista Research downgrades to hold from buy with a price target reduced from USD 49 to USD 37.
  • Clean Harbors, Inc.: Zacks downgrades to neutral from outperform with a price target reduced from USD 269 to USD 253.
  • Cytokinetics, Incorporated: Baptista Research upgrades to buy from outperform with a price target raised from USD 42.40 to USD 77.20.
  • Estee Lauder: Piper Sandler & Co upgrades to overweight from neutral with a target price raised from USD 95 to USD 114.
  • Sentinelone, Inc.: Wells Fargo upgrades to overweight from equalweight with a target price raised from USD 19 to USD 29.
  • Under Armour, Inc.: Baptista Research downgrades to hold from buy with a price target raised from USD 7.90 to USD 9.50.
  • New York Community Bancorp, Inc.: Compass Point Research & Trading maintains a neutral recommendation with a price target raised from 4.50 to USD 11.50.
  • Snowflake Inc.: Bernstein maintains its market perform recommendation with a price target reduced from 185 to USD 130. 
  • Wolfspeed, Inc.: Mizuho Securities maintains a neutral recommendation with a price target reduced from 28 to USD 17. 
  • Corteva, Inc.: CICC initiates an outperform recommendation with a target price of USD 62.
  • Epam Systems, Inc.: Deutsche Bank initiates a Hold recommendation with a target price of USD 204.
  • Admiral Group Plc: Jefferies upgrades to hold from underperform with a price target raised from GBX 2300 to GBX 3025.
  • Derwent London Plc: Berenberg maintains its buy recommendation and raises the target price from GBX 2494 to GBX 2700.